Cell No. : Cell Name
RCB2817 : A529L
update : 2024/04/04
|
Comment | Human cell line derived from lung adenosquamous cell carcinoma. HLA A2402/, B5201/, Cw01201/. |
Comment from the depositor | |
Terms and conditions | In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (Jpn J Clin Oncol 2001;31:311-317) designated by the DEPOSITOR is required. |
Remarks | |
Order Form |
Order Form(C-0005.pdf)
 
MTA(C-0007.pdf)
 
MTA(C-0007p.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Depositor |
Yasumoto, Kosei
|
Originator |
Yasumoto, Kosei
|
Year of deposit |
2008
|
Animal |
_human
< Mammals
|
Genus |
Homo
|
Species |
sapiens
|
Race |
Japanese
|
Gender |
Male
|
Age at sampling |
72 years
|
Tissue |
lung
|
Disease name |
adenosquamous cell carcinoma
|
Metastatic ability |
Yes
|
Classification |
cancer
|
Year of origin |
1996
|
|
Lifespan |
infinite
|
Morphology |
epithelial-like
|
Cellosaurus(Expasy) |
CVCL_8655
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
Culture medium |
|
RPMI1640 + 10% FBS
|
Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin + (0.02% EDTA or 0.04% EDTA)
|
Culture information
|
Passage ratio |
|
1 : 4 split
|
SC frequency |
|
Subculture : once/2 weeks, Medium Renewal : 2 times/week
|
Temperature |
|
37
℃
|
CO2 concentration |
|
5
%
|
Freeze medium |
|
Medium + 10% DMSO
|
Freezing method |
|
Slow freezing
|
Mycoplasma/Achoreplasma |
|
(-)
|
Isozyme |
|
LD, NP
|
STR(human) |
|
OK
|
Images |
deposit info | lot info |
|
|
Reference information |
Reference |
6
|
User's Publication |
1
|
Reference |
8991
Manabu Yasuda, Takeshi Hanagiri, Yoshiki Shigematsu, Takamitsu Onitsuka, Kouji Kuroda, Tetsurou Baba, Makiko Mizukami, Yoshinobu Ichiki, Hidetaka Uramoto, Mitsuhiro Takenoyama, Kosei Yasumoto
Identification of a Tumour Associated Antigen in Lung Cancer Patients With Asbestos Exposure
Anticancer Res
2010
30 (7), 2631-9
PubMed ID: 20682992
|
8995
Takashi Fukuyama, Yoshinobu Ichiki, Sousuke Yamada, Yoshiki Shigematsu, Tetsuro Baba, Yoshika Nagata, Makiko Mizukami, Masakazu Sugaya, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto
Cytokine Production of Lung Cancer Cell Lines: Correlation Between Their Production and the Inflammatory/Immunological Responses Both in Vivo and in Vitro
Cancer Sci
2007
98 (7), 1048-54
PubMed ID: 17511773
DOI: 10.1111/j.1349-7006.2007.00507.x
|
9004
Makiko Mizukami, Takeshi Hanagiri, Manabu Yasuda, Koji Kuroda, Yoshiki Shigematsu, Tetsuro Baba, Takashi Fukuyama, Yoshika Nagata, Tetsuya So, Yoshinobu Ichiki, Masakazu Sugaya, Tomoko So, Mitsuhiro Takenoyama, Kenji Sugio, Kosei Yasumoto
Antitumor Effect of Antibody Against a SEREX-defined Antigen (UOEH-LC-1) on Lung Cancer Xenotransplanted Into Severe Combined Immunodeficiency Mice
Cancer Res
2007
67 (17), 8351-7
PubMed ID: 17804751
DOI: 10.1158/0008-5472.CAN-06-3889
|
7413
Mizukami M, Hanagiri T, Baba T, Fukuyama T, Nagata Y, So T, Ichiki Y, Sugaya M, Yasuda M, Takenoyama M, Sugio K, Yasumoto K.
Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course.
Cancer Sci
2005
96(12):882-8
PubMed ID: 16367908
DOI: 10.1111/j.1349-7006.2005.00119.x
|
3626
So T, Takenoyama M, Sugaya M, Yasuda M, Eifuku R, Yoshimatsu T, Hanagiri T, Oyama T, Kodate M, Osaki T, Yasumoto K.
Generation of autologous tumor-specific T cell clones from a patient with adenosquamous carcinoma of the lung.
Jpn J Clin Oncol
2001
31(7):311-7
PubMed ID: 11518743
DOI: 10.1093/jjco/hye062
|
3636
Takenoyama M, Yoshino I, Eifuku R, So T, Imahayashi S, Sugaya M, Yasuda M, Inoue M, Ichiyoshi Y, Osaki T, Nagashima A, Nomoto K, Yasumoto K.
Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.
Jpn J Cancer Res
2001
92(3):309-15
PubMed ID: 11267941
DOI: 10.1111/j.1349-7006.2001.tb01096.x
|